ELCC 2017

1:33
Exciting current topics in lung cancer
Solange Peters
0:47
Why is European Lung Cancer Conference so important?
Solange Peters
2:43
Increasing patient access to the latest treatments
Solange Peters
1:46
Challenges and opportunities for patients with advanced NSCLC
Solange Peters
2:29
The open questions surrounding immunotherapy and targeted therapy in lung cancer
Solange Peters
1:10
The BIRCH trial data discussed by Dr Peters
Solange Peters
1:29
The LUME-BioNIS study and its aims
Keith Kerr
2:04
Biomarker testing in NSCLC
Keith Kerr
0:51
Current treatment landscape for neuroendocrine tumors
Keith Kerr
1:48
Evolving guidelines for molecular testing in lung cancer
Fred Hirsch
1:13
Phase II study of Durvalumab for patients with NSCLC
David Gandara
2:07
Increasing treatment options for NSCLC
David Gandara
2:09
Benefits of targeted therapeutics in Lung Cancer
David Carbone
1:15
Molecular tools for lung cancer therapies
Charles Swanton
1:52
ESMO guidelines for thymic cancer management
Nicolas Girard
1:00
The genetic landscape of lung cancer
Martin Reck
VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

VJO needs the contact information you provide to inform you about our latest oncology news and videos, educational courses and industry supported content (some of which may be promotional in nature). You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.

The content of VJOncology is intended for healthcare professionals